Fibromyalgia Trial, Recruiting (NCT06892041)

Fibromyalgia Trial, Recruiting NCT06892041 Sponsor: Weill Medical College of Cornell University Condition: Fibromyalgia

Printed from Voxsanity (voxsanity.com.au) — NCT06892041 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Fibromyalgia

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 to 65 years old, of any gender
People who are able to give their informed consent to participate
People whose symptoms meet the criteria for normal, latent, or active temporomandibular myofascial pain (jaw and facial muscle pain — confirm with trial site)

Who may not be able to join:

People who cannot have an MRI scan, including those with severe obesity, difficulty lying flat, intracranial clips, metal implants, metallic devices or objects within 10mm of the head, a history of metal in the eyes (such as from welding), claustrophobia, or a cardiac pacemaker or pacing wires
People who are currently pregnant or breastfeeding
People who have had a traumatic injury to the jaw muscles or jaw joint in the last 12 months
People who have had a jaw fracture in the last 12 months
People who have started a new treatment for myofascial pain within the past month
People who have received Botox injections in the masseter (jaw) muscle within the last 4 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gene Kim, PhD, Weill Medical College of Cornell University

Phone: 646-962-8394

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06892041

Sponsor: Weill Medical College of Cornell University

Phase: Not Applicable

Status: Recruiting

Condition: Fibromyalgia

Trial contact: 646-962-8394

More information: https://clinicaltrials.gov/study/NCT06892041

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 to 65 years old, of any gender
People who are able to give their informed consent to participate
People whose symptoms meet the criteria for normal, latent, or active temporomandibular myofascial pain (jaw and facial muscle pain — confirm with trial site)

Who may not be able to join:

People who cannot have an MRI scan, including those with severe obesity, difficulty lying flat, intracranial clips, metal implants, metallic devices or objects within 10mm of the head, a history of metal in the eyes (such as from welding), claustrophobia, or a cardiac pacemaker or pacing wires
People who are currently pregnant or breastfeeding
People who have had a traumatic injury to the jaw muscles or jaw joint in the last 12 months
People who have had a jaw fracture in the last 12 months
People who have started a new treatment for myofascial pain within the past month
People who have received Botox injections in the masseter (jaw) muscle within the last 4 months

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Weill Medical College of Cornell University

Registry

ClinicalTrials.gov

Start date

4 September 2025

Est. completion

1 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Difference in mean diffusion MRI parameters of temporalis and masseter muscles between patients at the normal stage and those at the latent/active pain stage.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov